【摘要】目的探讨血液透析用带隧道带涤纶套导管相关血流感染的病原学分布及临床特点。方法回顾性分析55 例2008 年8 月~2018 年8 月于北京大学第一医院确诊为血液透析用带隧道带涤纶套导管相关血流感染者的临床资料。结果发热、外出口感染、隧道感染及新发导管功能不良的发生率依次为100%、21.8%、7.3%及20.0%。抗生素使用前外周血培养(100% 比81.5%,P=0.047)及导管血培养阳性率(93.3%比61.5%,P=0.028)均高于抗生素使用后组。77 份阳性标本中,革兰阳性菌、革兰阴性菌和真菌分
别占45.5%、53.2%及1.3%,耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)为最常见病原菌(19.5%)。结论规范化留取病原学标本对于导管相关血流感染诊断至关重要,笔者所在中心革兰阴性菌感染率较高,经验性治疗时除针对MRSA 外,还需考虑覆盖革兰阴性菌。
【Abstract】Objective To investigate microbiological and clinical characteristics of tunnelled and cuffed hemodialysis catheter- related bloodstream infections (CRBSIs). Methods The medical records of all patients with confirmed CRBSIs diagnosed in Peking University First Hospital from August 2008 to August 2018 were retrospectively reviewed, and 55 cases with CRBSIs were enrolled. Clinical and microbiological data were collected and analyzed. Results Fever, exit-site infection, tunnel infection and catheter dysfunction were observed in 100%, 21.8%, 7.3% and 20.0% respectively of the cases. The positive rates of blood cultures from peripheral blood (100% vs. 81.5% , P=0.047) and blood within catheters (93.3% vs. 81.5% , P=0.028) before antimicrobial therapy were significantly higher than those after antimicrobial therapy. There were 77 positive cultures that yielded 45.5% Gram-positive, 53.2% Gram-negative and 1.3% fungal isolates. The most common organism isolated was methicillin-resistant staphylococcus aureus (MRSA,19.5%). Conclusion Standardized collection of specimens is essential for the diagnosis of CRBSIs. Gram-negative isolates accounted for most tunnelled CRBSIs in our center. For patients with suspected CRBSIs, the empirical antibiotic regimen should include agents actively against both MRSA and Gram-negative bacteria.
[1]Hemodialysis Adequacy Work G.Clinical practice guidelines for hemodialysis adequacy, update 2006.[J].Am J Kidney Dis, 2006, 48(Suppl 1):S2-90
[2]Voelker R.Updated guidelines target reductions in catheter-related bloodstream infections[J].JAMA, 2011, 305(17):1753-1754
[3]Mermel LA, Allon M, Bouza E, et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America[J].Clin Infect Dis, 2009, 49(1):1-45
[4]Weijmer MC, Vervloet MG, ter Wee PM.Compared to tunnelled cuffed haemodialysis catheters,temporary untunnelled catheters are associated with more complications already within 2 weeks of use[J].Nephrol Dial Transplant, 2004, 19(3):670-677
[5]Inrig JK, Reed SD, Szczech LA, et al.Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia[J].Clin J Am Soc Nephrol, 2006, 1(3):518-524
[6]Allon M.Dialysis catheter-related bacteremia: treatment and prophylaxis[J].Am J Kidney Dis, 2004, 44(5):779-791
[7]Stroz MJ, Nathoo B, Stroz PM.Posteriorly tunnelled dialysis catheters for permanent use in cognitively impaired patients undergoing hemodialysis[J].J Vasc Interv Radiol, 2014, 25(10):1621-1625
[8]Sedlacek M, Gemery JM, Cheung AL, et al.Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunnelled catheters[J].Am J Kidney Dis, 2007, 49(3):401-408
[9]Saad TF, Weiner HL.Venous Hemodialysis Catheters and Cardiac Implantable Electronic Devices: Avoiding a High-Risk Combination[J].Semin Dial, 2017, 30(3):187-192
[10]Sychev D, Maya ID, Allon M.Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection[J].Semin Dial, 2011, 24(2):239-241
[11]Lata C, Girard L, Parkins M, et al.Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review[J]. Can J Kidney Health Dis, 2016, 3:24-24
[12]Martinez JA, DesJardin JA, Aronoff M, et al.Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients[J].Crit Care Med, 2002, 30(1):7-13
[13]Norberg A, Christopher NC, Ramundo ML, et al.Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter[J].Jama, 2003, 289(6):726-729
[14]Teo BW, Sau PY, Xu H, et al.Microbiology of tunnelled catheter-related infections in a multi-ethnic South-east Asian patient population[J].Nephron Clin Pract, 2011, 118(2):c86-92
[15]Al-Solaiman Y, Estrada E, Allon M.The spectrum of infections in catheter-dependent hemodialysis patients[J].Clin J Am Soc Nephrol, 2011, 6(9):2247-2252
[16]Maya ID, Carlton D, Estrada E, et al.Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report[J].Am J Kidney Dis, 2007, 50(2):289-295
[17]Marr KA, Sexton DJ, Conlon PJ, et al.Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis[J].Ann Intern Med, 1997, 127(4):275-280
[18]中国医院协会血液净化中心管理分会血液净化通路学组.中国血液透析用血管通路专家共识第版[J].中国血液净化, 2014, 13(8):549-558
[19]Saleh HM, Tawfik MM, Abouellail H.Prospective,randomized study of long-term hemodialysis catheter removal versus guidewire exchange to treat catheter-related bloodstream infection[J].J Vasc Surg, 2017, 66(5):1427-1431
[20]Funalleras G, Fernandez-Hidalgo N, Borrego A, et al.Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study[J].Clin Infect Dis, 2011, 53(9):e129-132
[21]Yen HW, Yang WC, Tarng DC, et al.Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunnelled,cuffed hemodialysis catheters: retrospective single center analysis[J].Hemodial Int, 2016, 20(2):315-320